Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to -$24.6 million.

  • Fortress Biotech's Net Cash Flow rose 168.20% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.5 million, marking a year-over-year increase of 291.79%. This contributed to the annual value of -$24.6 million for FY2024, which is 74.84% up from last year.
  • As of FY2024, Fortress Biotech's Net Cash Flow stood at -$24.6 million, which was up 74.84% from -$97.6 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Net Cash Flow registered a high of $81.6 million during FY2020, and its lowest value of -$127.0 million during FY2022.
  • For the 3-year period, Fortress Biotech's Net Cash Flow averaged around -$83.0 million, with its median value being -$97.6 million (2023).
  • As far as peak fluctuations go, Fortress Biotech's Net Cash Flow plummeted by 274.06% in 2022, and later spiked by 74.84% in 2024.
  • Fortress Biotech's Net Cash Flow (Yearly) stood at $81.6 million in 2020, then dropped by 10.54% to $73.0 million in 2021, then plummeted by 274.06% to -$127.0 million in 2022, then climbed by 23.16% to -$97.6 million in 2023, then soared by 74.84% to -$24.6 million in 2024.